{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/6419a446e1925b001131f24e/6a15ab51cb11d38a8bcc3c37?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Tackling dementia underdiagnosis and supporting patients and families, with Dr Alistair Robertson","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/6419a446e1925b001131f24e/1779804907364-302833a5-6961-4491-8e92-d1892b6cfef3.jpeg?height=200","description":"<p>Around a third of patients with dementia remain undiagnosed. Dr Alistair Robertson, a GP with an extended role in frailty, provides insights for GPs and other primary care professionals on how they can address&nbsp; underdiagnosis and provide support for patients and their families. He covers signs and symptoms to look out for, assessments to conduct, the role of drug treatments, and the benefits of honest conversations with patients and families.</p><p><br></p><p>Educational objectives</p><p><br></p><p>After listening to this podcast, healthcare professionals should be better able to:</p><ul><li>Consider the number of patients in their practice who may have undiagnosed dementia</li><li>Reflect on differential diagnoses and how to take a good history</li><li>Recall key signs and symptoms to look out for and how these may differ in different types of dementia</li><li>Understand the role of cognitive assessment tools and how to use them</li><li>Review current drug treatments and their effectiveness</li><li>Explore how to address polypharmacy</li><li>Understand the importance of early, honest conversations with patients and families</li></ul><p><br></p><p>You can access the website version of this podcast, along with a list of key learning points and downloadable notes written by Dr Robertson, on <a href=\"https://www.mimslearning.co.uk/courses/podcast-diagnosing-and-managing-dementia-with-dr-alistair-robertson\" rel=\"noopener noreferrer\" target=\"_blank\">MIMS Learning</a>. MIMS Learning offers hundreds of hours of CPD for healthcare professionals, along with a handy CPD organiser and note-taking for appraisal.</p><p><br></p><p>Please note: this podcast is presented by medical editors and discusses educational content written or presented by doctors, nurses and other healthcare professionals on the MIMS Learning website and at live events.</p><p><br></p><p><strong>MIMS Learning</strong></p><p><a href=\"https://www.mimslearning.co.uk/register\" rel=\"noopener noreferrer\" target=\"_blank\"><strong>Register for a FREE account</strong></a></p><p><br></p><p>Related resources from MIMS Learning and MIMS</p><p><br></p><p><a href=\"https://docs.google.com/document/d/16i960m_fjl7XmAWjWUGYMnpHVT55KBf-/edit?usp=sharing&amp;ouid=107149777841309994157&amp;rtpof=true&amp;sd=true\" rel=\"noopener noreferrer\" target=\"_blank\">Practical advice for GPs on dementia</a> document created by Dr Alistair Robertson.</p><p><a href=\"https://www.mimslearning.co.uk/learn/enroll/4c7588d1-7e3d-481f-9536-397877d450dc\" rel=\"noopener noreferrer\" target=\"_blank\">Frailty: clinical review</a></p><p><a href=\"https://www.mimslearning.co.uk/courses/guidance-update-sign-guidelines-for-support-of-people-with-dementia-and-their-carers\" rel=\"noopener noreferrer\" target=\"_blank\">Guidance update: SIGN guidelines for support of people with dementia and their carers</a></p><p><a href=\"https://www.mimslearning.co.uk/courses/polypharmacy-in-a-patient-with-dementia-nursing-home-case-study\" rel=\"noopener noreferrer\" target=\"_blank\">Polypharmacy in a patient with dementia: nursing home case study</a></p><p><a href=\"https://www.mims.co.uk/anticholinergic-cognitive-burden-acb-scores-commonly-used-drugs/elderly-care/article/1899512\" rel=\"noopener noreferrer\" target=\"_blank\">Anticholinergic cognitive burden (ACB) scores for commonly used drugs</a></p>","author_name":"MIMS Learning"}